These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10116667)

  • 1. The Sporicidin recall.
    Healthc Hazard Mater Manage; 1992 Jan; 5(4):9-11. PubMed ID: 10116667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporicidin responds to the recall of its products.
    Healthc Hazard Mater Manage; 1992 Aug; 5(11):8-11. PubMed ID: 10121070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporicidin update: are the government's regulatory teeth tearing a hole in industry?
    Healthc Hazard Mater Manage; 1993 Apr; 6(7):10-1. PubMed ID: 10125098
    [No Abstract]   [Full Text] [Related]  

  • 4. Glutaraldehyde sterilants: FDA vs. APIC soaking times.
    Healthc Hazard Mater Manage; 1995 Jun; 8(9):1-2. PubMed ID: 10143314
    [No Abstract]   [Full Text] [Related]  

  • 5. Federal regulatory action against sporicidin cold sterilizing solution.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Dec; 40(50):880-1. PubMed ID: 1749372
    [No Abstract]   [Full Text] [Related]  

  • 6. EPA updates its recent actions on sterilants made by 4 firms.
    Fehrenbach MP
    Health Facil Manage; 1994 May; 7(5):44, 46, 48-9. PubMed ID: 10133732
    [No Abstract]   [Full Text] [Related]  

  • 7. New glutaraldehyde labeling controversial.
    Patterson P
    OR Manager; 1995 Sep; 11(9):26. PubMed ID: 10144942
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL
    J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
    [No Abstract]   [Full Text] [Related]  

  • 9. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Sep; 73(189):56487-91. PubMed ID: 18985960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cold sterilant update: EPA acts on efficacy test results.
    Fehrenbach MP
    Mater Manag Health Care; 1994 May; 3(5):62, 64, 66. PubMed ID: 10133840
    [No Abstract]   [Full Text] [Related]  

  • 11. Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Oct; 72(201):58993-9000. PubMed ID: 17966558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disinfectants.
    Fluke C
    J Healthc Mater Manage; 1992 Aug; 10(7):73-4. PubMed ID: 10119554
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL
    Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773
    [No Abstract]   [Full Text] [Related]  

  • 16. MEDWatch: the new FDA medical products reporting program.
    Kessler DA
    Am J Hosp Pharm; 1993 Jun; 50(6):1151-2. PubMed ID: 8517452
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA asks LyphoMed to recall intravenous solution.
    Wagner M
    Mod Healthc; 1988 Jul; 18(31):5. PubMed ID: 10288204
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical devices; illustrative and designated lists for device tracking--FDA. Final rule and request for comments.
    Fed Regist; 1993 Aug; 58(156):43451-5. PubMed ID: 10171508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEDWATCH: the new FDA medical products reporting program.
    Kennedy DL
    Respir Care; 1993 Oct; 38(10):1077-80. PubMed ID: 10145891
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical postmarket review: fact or fiction?
    Schanz SJ
    Food Drug Law J; 2007; 62(3):493-500. PubMed ID: 17915391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.